Abstract:Aims Serine/threonine/tyrosine kinase 1 (STYK1) has been previously shown to have oncogenic properties, and emerging evidence suggests that STYK1 expression correlates with epithelial-mesenchymal transition (EMT). However, the mechanism of STYK1 involvement in oncogenesis remains unknown. The present study aimed to elucidate how STYK1 expression level relates to the metastasis, migration, invasion, and EMT in non-small cell lung cancer (NSCLC) and to determine the molecular mechanism of STYK1 effects. Methods Serine/threonine/tyrosine kinase 1 (STYK1) expression level and its relationship with the prognosis of NSCLC were determined using the ONCOMINE database and clinical cases. Non-small cell lung cancer cell lines with the overexpression or knockdown of STYK1 were established to determine whether STYK1 promotes cell migration, invasion, and EMT in vitro and in vivo . In addition, a constitutively active FoxO1 mutant (FoxO1AAA) was used to examine the role of FoxO1 in the STYK1-mediated upregulation of metastasis and EMT in NSCLC. Results Serine/threonine/tyrosine kinase 1 (STYK1) was upregulated in NSCLC tissues and cell lines, and its overexpression correlated with poor prognosis in patients with NSCLC after surgery. Enhanced expression of STYK1 potentiated the migration, invasion, and EMT in SW900 cells, thereby promoting metastasis, whereas knockdown of STYK1 inhibited these cellular phenomena in Calu-1 cells. Furthermore, STYK1 expression was positively related to the level of phosphorylated-FoxO1, whereas the constitutively active FoxO1 mutant protected against the positive effect of STYK1 overexpression on cell migration, invasion, and EMT. Conclusion Serine/threonine/tyrosine kinase 1 (STYK1) was upregulated in NSCLC and correlated with poor clinical outcomes. In addition, STYK1 suppressed FoxO1 functions, thereby promoting metastasis and EMT in NSCLC.

NOK/STYK1 Interacts with GSK-3β and Mediates Ser9 Phosphorylation Through Activated Akt

Nok Interacts With Akt And Enhances Its Activation

NOK promotes tumorigenesis through coordinating epidermal growth factor receptor to boost the downstream signaling in breast cancer

NOK/STYK1 Promotes the Genesis and Remodeling of Blood and Lymphatic Vessels During Tumor Progression

NOK Associates with C-Src and Promotes C-Src-induced STAT3 Activation and Cell Proliferation.

A Novel Protein Tyrosine Kinase Nok That Shares Homology With Platelet-Derived Growth Factor/Fibroblast Growth Factor Receptors Induces Tumorigenesis And Metastasis In Nude Mice

NOK/STYK1 Has a Strong Tendency Towards Forming Aggregates and Colocalises with Epidermal Growth Factor Receptor in Endosomes

Nok Activates Stat3 Signaling by A Jak2-Dependent Mechanism

High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.

Transmembrane Helix of Novel Oncogene with Kinase-Domain (NOK) Influences Its Oligomerization and Limits the Activation of RAS/MAPK Signaling

Generation and application of the NOK/STYK1 monoclonal antibody

Obg-Like Atpase 1 Regulates Global Protein Serine/Threonine Phosphorylation In Cancer Cells By Suppressing The Gsk3 Beta-Inhibitor 2-Pp1 Positive Feedback Loop

STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling

[Expression and its Clinical Significance of NOK, EGFR in NSCLC.].

The Carboxyl Terminal Tyrosine 417 Residue of Nok Has an Autoinhibitory Effect on Nok-Mediated Signaling Transductions

Point Mutation at Single Tyrosine Residue of Novel Oncogene Nok Abrogates Tumorigenesis in Nude Mice

I Kappa B Kinase Epsilon And Tank-Binding Kinase 1 Activate Akt By Direct Phosphorylation

Protein Kinase STK24 Promotes Tumor Immune Evasion Via the AKT‐PD‐L1 Axis

STK31 Regulates the Proliferation and Cell Cycle of Lung Cancer Cells Via the Wnt/β‑catenin Pathway and Feedback Regulation by C‑myc.

Proto-oncogene TCL1: more than just a coactivator for Akt

STYK1 mediates NK cell anti-tumor response through regulating CCR2 and trafficking